Burning Rock Biotech (BNR) Cash from Financing Activities (2019 - 2025)
Burning Rock Biotech (BNR) posted quarterly Cash from Financing Activities of -$14000.0 for Q4 2025, down 40.0% year-over-year from -$23333.3 in Q4 2024, and down 105.02% quarter-over-quarter from $279000.0 in Q2 2025.
Burning Rock Biotech (BNR) Cash from Financing Activities (2019 - 2025) Analysis & Trends
Burning Rock Biotech's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$14000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 40.0% year-over-year to -$14000.0; the TTM figure through Dec 2025 stood at $255279.1 (up 188.31% YoY), while the FY2025 annual figure was $272000.0, up 2820.0% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$14000.0, down from $279000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $279000.0 in Q2 2025, with the low at -$12.5 million in Q4 2022.
- The 5-year median for Cash from Financing Activities is -$375000.0 (2022), against an average of -$2.3 million.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities plunged 1577.07% in 2023, then soared 100.0% in 2024.
- Burning Rock Biotech's Cash from Financing Activities stood at -$1.1 million in 2021, then sank by 1073.99% to -$12.5 million in 2022, then surged by 97.85% to -$269000.0 in 2023, then soared by 96.28% to -$10000.0 in 2024, then sank by 40.0% to -$14000.0 in 2025.
- Business Quant data shows BNR's Cash from Financing Activities at -$14000.0 in Q4 2025, $279000.0 in Q2 2025, and -$10000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | 279.06 |
| Sep 30, 2024 | 279.06 |
| Mar 31, 2024 | -10,348.62 |
| Mar 31, 2024 | -10,348.62 |
| Dec 31, 2023 | -269,000.00 |
| Dec 31, 2023 | -269,000.00 |
| Sep 30, 2023 | -6.29 Mn |
| Sep 30, 2023 | -6.29 Mn |
| Jun 30, 2023 | -138,000.00 |
| Jun 30, 2023 | -138,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | -12.50 Mn |
| Dec 31, 2022 | -12.50 Mn |